|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | N/A | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
| 化学式 | C31H44ClFN8O3 |
|||
| 分子量 | 631.18 | CAS No. | 1177827-73-4 | |
| Solubility (25°C)* | 体外 | DMSO | 100 mg/mL (158.43 mM) | |
| Ethanol | 100 mg/mL (158.43 mM) | |||
| Water | 9 mg/mL (14.25 mM) | |||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
||||
| 製品説明 | AP-III-a4 (ENOblock) is the first nonsubstrate analogue inhibitor of enolase with IC50 of 0.576 μM. |
|---|---|
| in vitro | In HCT116 cells, AP-III-a4 (ENOblock) induces cell death under hypoxia and inhibits cancer cell migration and invasion by down-regulation of AKT and Bcl-xL expression. In Huh7 hepatocytes and HEK kidney cells, it also induces glucose uptake and inhibits phosphoenolpyruvate carboxykinase (PEPCK) expression. [1] |
| in vivo | In a HCT116-xenotransplanted zebrafish tumor xenograft model, AP-III-a4 (ENOblock) (10 μM) inhibits cancer cell migration and invasion processes. In vivo, it also causes downregulation of PEPCK expression and induction of glucose uptake, and inhibits adipogenesis and foam cell formation. [1] |
| キナーゼアッセイ | Enolase activity assay | |
|---|---|---|
| Enolase activity is measured at 37°C by incubating pure enolase (3–9 U) in a buffer containing 50 mM imidazole-HCl (pH 6.8), 2.0 mM MgSO4 and 400 mM KCl in the absence or presence of AP-III-a4 (ENOblock) or NaF. A single unit of enolase is defined as the amount of enzyme that produces 1 μmol of phosphoenol pyruvate from phospho-D-glycerate/min in standard assay. The reaction is initiated by adding 1 μmol of 2-phospho-D-glycerate, and the OD is measured after 10 min of reaction time with a spectrophometer at 240 nm. | ||
| 細胞アッセイ | 細胞株 | HCT116 cells |
| 濃度 | 5 μM | |
| 反応時間 | 24 h | |
| 実験の流れ | AP-III-a4 (ENOblock) is used to treat 3 x 105 HCT116 cells seeded in a 6 well plate for 24 h, with or without prior induction of hypoxia for 4 h, using triplicate wells. After 24 h of treatment with this compound, cells are trypsinized and resuspended in 2.5 mL PBS. A 100 μL aliquot is taken for staining with 0.2% trypan blue solution and counted using a hemocytometer. 150 cells are counted and dead cells are classified as those that could not exclude trypan blue. |
|
| 動物実験 | 動物モデル | HCT116-xenotransplanted zebrafish tumor xenograft model |
| 投薬量 | 10 μM | |
| 投与方法 | -- | |
|
| LncPRESS1 promotes the progression and cisplatin resistance of breast cancer through upregulation of ENO1 and activation of glycolysis [ Cell Div, 2025, 20(1):23] | PubMed: 41046264 |
| Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development [ J Exp Clin Cancer Res, 2023, 42(1):1] | PubMed: 36588153 |
| Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections [ bioRxiv, 2023, 10.1101/2023.08.01.551011] | PubMed: None |
| A temperature-regulated circuit for feeding behavior [ Nat Commun, 2022, 13(1):4229] | PubMed: 35869064 |
| A temperature-regulated circuit for feeding behavior [ Nat Commun, 2022, 13(1):4229] | PubMed: 35869064 |
| The essential roles of m6A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma [ J Exp Clin Cancer Res, 2022, 41(1):36] | PubMed: 35078505 |
| Amoxicillin Haptenation of α-Enolase is Modulated by Active Site Occupancy and Acetylation [ Front Pharmacol, 2021, 12:807742] | PubMed: 35095517 |
| Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma. [ Oncogene, 2020, 39(13):2786-2796] | PubMed: 32024967 |
| FGFRL1 affects chemoresistance of small-cell lung cancer by modulating the PI3K/Akt pathway via ENO1. [ J Cell Mol Med, 2020, 24(3):2123-2134] | PubMed: 31957179 |
| The Synergism of the Small Molecule ENOblock and Fluconazole Against Fluconazole-Resistant Candida albicans. [ Front Microbiol, 2019, 10:2071] | PubMed: 31555252 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。